Evidence map›Paper›PMID 30301788›Full record

ArticleScience signaling2018

IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA binding protein Arid5a.

Nilesh Amatya, Erin E Childs, J Agustin Cruz, Felix E Y Aggor, Abhishek V Garg, Andrea J Berman, Johann E Gudjonsson, Ulus Atasoy, Sarah L Gaffen

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Regulation and Function of the Atypical IκBs-Bcl-3, IκBEuropean journal of immunology · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The IL-17 pathway intertwines with neurotrophin and TLR/IL-1R pathways since its domain shuffling origin.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Nilesh AmatyaDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0002-7942-1742
Erin E ChildsDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
J Agustin CruzDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0002-4927-9140
Felix E Y AggorDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Abhishek V GargDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Andrea J BermanDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0003-1217-7412
Johann E GudjonssonDepartment of Dermatology, Taubman Center, University of Michigan, Ann Arbor, MI 48109, USA.
Ulus AtasoyDivision of Allergy and Immunology, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0002-4095-1359
Sarah L GaffenDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA. sarah.gaffen@pitt.edu.ORCID 0000-0001-8511-2041
University of Pittsburgh · USA. Alfred Taubman Health Care Center · USUniversity of Michigan · US

Funding

University of Michigan Skin Biology and Diseases Resource-based CenterP30AR075043 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson · 2019 to 2026
$6.6M
Host and Fungal Regulation of Type 17 Immunity to Oral CandidiasisR37DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2017 to 2026
$5.6M
Role of the sex biased transcription factor VGLL3 in promoting autoimmune responses in SLER01AI130025 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson · 2017 to 2026
$3.9M
HuR in Allergic Asthma and T Cell DifferentiationR01AI080870 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI ATASOY, ULUS · 2009 to 2019
$3.6M
Role of IL-13 and the IL-13 Associated rs20541 Risk Variant in the Pathogenesis of PsoriasisR01AR069071 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GUDJONSSON, JOHANN ELI · 2015 to 2019
$2.1M
IL-17 Receptor Signaling in the Oral MucosaR01DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2012 to 2016
$2.1M
IL-23/STAT3-Driven Oral Immune Responses to Candida albicansR01DE023815 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2014 to 2018
$1.9M
Negative Control of IL-17R Signaling: Implications for Fungal ImmunityR01AI107825 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2014 to 2018
$1.9M
Mechanisms of mRNA regulation by La-related protein 1R01GM116889 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BERMAN, ANDREA J. · 2016 to 2021
$1.6M
IL-17 Isoforms in Organ Specific AutoimmunityR21AI128991 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2017 to 2018
$423k
NIAID NIH HHS R01 AI080870NIAID NIH HHS R01 AI107825NIAID NIH HHS R01 AI130025NIAID NIH HHS R21 AI128991NIAMS NIH HHS P30 AR075043NIAMS NIH HHS R01 AR069071NIDCR NIH HHS R01 DE023815NIDCR NIH HHS R37 DE022550NIGMS NIH HHS R01 GM116889
6 · The paper itself

Abstract

Interleukin-17A (IL-17A) not only stimulates immunity to fungal pathogens but also contributes to autoimmune pathology. IL-17 is only a modest activator of transcription in experimental tissue culture settings. However, IL-17 controls posttranscriptional events that enhance the expression of target mRNAs. Here, we showed that the RNA binding protein (RBP) Arid5a (AT-rich interactive domain-containing protein 5a) integrated multiple IL-17-driven signaling pathways through posttranscriptional control of mRNA. IL-17 induced expression of Arid5a, which was recruited to the adaptor TRAF2. Arid5a stabilized IL-17-induced cytokine transcripts by binding to their 3' untranslated regions and also counteracted mRNA degradation mediated by the endoribonuclease MCPIP1 (Regnase-1). Arid5a inducibly associated with the eukaryotic translation initiation complex and facilitated the translation of the transcription factors (TFs) IκBζ (

Indexed as

Signal Transduction3' Untranslated RegionsAdaptor Proteins, Signal TransducingAnimalsCCAAT-Enhancer-Binding Protein-betaCytokinesDNA-Binding ProteinsFibroblastsHEK293 CellsHumansInflammationInterleukin-17KeratinocytesMiceMice, Inbred C57BLMice, Knockout3' Untranslated RegionsAdaptor Proteins, Signal TransducingARID5A protein, humanArid5a protein, mouseCCAAT-Enhancer-Binding Protein-betaCebpb protein, mouseCytokinesDNA-Binding ProteinsIL17A protein, humanIl17a protein, mouseInterleukin-17Nfkbiz protein, mouseNuclear ProteinsRibonucleasesRNA-Binding ProteinsRNA, MessengerTNF Receptor-Associated Factor 2TRAF2 protein, mouseTranscription FactorsZc3h12a protein, mouse

Identifiers

PMID30301788
PMCPMC6188668
OpenAlexW2896648763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.